MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and other
comprehensive loss for the...
-$8,058K
(24.13%↑ Y/Y)
CA
$2,086K
US
$777K
(210.80%↑ Y/Y)
CA
$1,485K
US
$839K
(-35.11%↓ Y/Y)
DE
$150K
Net loss attributed
to shareholders...
-$7,053K
(34.23%↑ Y/Y)
Foreign currency
translation adjustment
-$1,005K
(-1075.73%↓ Y/Y)
Net foreign
exchange (gain) loss
$616K
(1521.05%↑ Y/Y)
Net finance
(income) expense
$377K
(-15.28%↓ Y/Y)
Capital Equipment
$2,863K
(249.15%↑ Y/Y)
Recurring Non Capital
$2,474K
(37.37%↑ Y/Y)
Net loss before
income taxes
-$7,028K
(34.21%↑ Y/Y)
Total income tax
expense
$25K
(-39.02%↓ Y/Y)
Total other (income)
expenses
$993K
(105.59%↑ Y/Y)
Deferred tax expense
(recovery)
-$2K
Revenue (note 12)
$5,337K
(103.62%↑ Y/Y)
Operating loss
-$8,021K
(28.17%↑ Y/Y)
Income tax expense
$27K
(-34.15%↓ Y/Y)
Gross profit
$3,832K
(106.80%↑ Y/Y)
Cost of sales
$1,505K
(95.96%↑ Y/Y)
Total operating
expenses
$11,853K
(-8.96%↓ Y/Y)
Selling, general and
administrative
$6,591K
(-19.73%↓ Y/Y)
Research and development
$5,262K
(9.44%↑ Y/Y)
Back
Back
Income Statement
Profound Medical Corp. (PROF)
Profound Medical Corp. (PROF)
source: myfinsight.com